Co-Diagnostics, Inc. (CODX) — Stock Valuation & Research

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three…

CODX key statistics

Price$0.38
Market cap$2.79M
SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
52-week range0.35-13.54
Beta3.16

Explore CODX's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.